All Stories

  1. Potency of Human Cardiosphere-Derived Cells from Patients with Ischemic Heart Disease Is Associated with Robust Vascular Supportive Ability

    Article • Stem Cells Translational Medicine, February 2017, Wiley

    Enca Martin-Rendon, Dr Pilar Sepulveda

  2. Cell therapy for heart disease: Trial sequential analyses of two Cochrane reviews

    Article • Clinical Pharmacology & Therapeutics, May 2016, Wiley

    Enca Martin-Rendon

  3. Stem cell treatment for acute myocardial infarction

    Article • Cochrane Database of Systematic Reviews, September 2015, Wiley

    Enca Martin-Rendon

  4. CXCR 2 modulates bone marrow vascular repair and haematopoietic recovery post‐transplant

    Article • British Journal of Haematology, March 2015, Wiley

    Enca Martin-Rendon

  5. The emerging roles of TCF4 in disease and development

    Article • Trends in Molecular Medicine, June 2014, Elsevier

    Enca Martin-Rendon

  6. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure

    Article • April 2014, Wiley

    Enca Martin-Rendon, Ms Susan Jane Brunskill

  7. Blood vessel repair and regeneration in the ischaemic heart

    Article • Open Heart, February 2014, BMJ

    Enca Martin-Rendon

  8. Knockdown of Human TCF4 Affects Multiple Signaling Pathways Involved in Cell Survival, Epithelial to Mesenchymal Transition and Neuronal Differentiation

    Article • PLoS ONE, August 2013, PLOS

    Enca Martin-Rendon

  9. Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis

    Article • PLoS ONE, June 2013, PLOS

    Enca Martin-Rendon, Ms Susan Jane Brunskill

  10. Erratum to: Human Cardiosphere-Derived Cells from Patients with Chronic Ischaemic Heart Disease Can Be Routinely Expanded from Atrial but Not Epicardial Ventricular Biopsies

    Article • Journal of Cardiovascular Translational Research, July 2012, Springer Science + Business Media

    Enca Martin-Rendon

  11. Human Cardiosphere-Derived Cells from Patients with Chronic Ischaemic Heart Disease Can Be Routinely Expanded from Atrial but Not Epicardial Ventricular Biopsies

    Article • Journal of Cardiovascular Translational Research, July 2012, Springer Science + Business Media

    Enca Martin-Rendon

  12. Long-Term Effects of Autologous Bone Marrow Stem Cell Treatment in Acute Myocardial Infarction: Factors That May Influence Outcomes

    Article • PLoS ONE, May 2012, PLOS

    Enca Martin-Rendon, Ms Susan Jane Brunskill

  13. Stem cell treatment for acute myocardial infarction

    Article • February 2012, Wiley

    Enca Martin-Rendon, Ms Susan Jane Brunskill

  14. Cryopreservation of human bone marrow‐derived mesenchymal stem cells with reduced dimethylsulfoxide and well‐defined freezing solutions

    Article • Biotechnology Progress, November 2010, Wiley

    Enca Martin-Rendon

  15. Functional and Morphological Maturation of Implanted Neonatal Cardiomyocytes as a Comparator for Cell Therapy

    Article • Stem Cells and Development, July 2010, Mary Ann Liebert Inc

    Enca Martin-Rendon, Prof. Kieran Clarke

  16. Clinical stem cell therapies for severe autoimmune diseases

    Article • Transfusion Medicine, September 2009, Wiley

    Enca Martin-Rendon

  17. Route of delivery and baseline left ventricular ejection fraction, key factors of bone‐marrow‐derived cell therapy for ischaemic heart disease

    Article • European Journal of Heart Failure, August 2009, Wiley

    Enca Martin-Rendon, Ms Susan Jane Brunskill

  18. Stem cell‐related therapies for vascular diseases

    Article • Transfusion Medicine, August 2009, Wiley

    Enca Martin-Rendon

  19. Stem cell therapy for ischaemic heart disease and congestive heart failure

    Article • July 2009, Wiley

    Enca Martin-Rendon, Ms Susan Jane Brunskill

  20. Stem cell treatment for acute myocardial infarction

    Article • October 2008, Wiley

    Enca Martin-Rendon, Ms Susan Jane Brunskill

  21. 5‐Azacytidine‐treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies

    Article • Vox Sanguinis, July 2008, Wiley

    Enca Martin-Rendon

  22. Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study

    Article • AJP Heart and Circulatory Physiology, June 2008, American Physiological Society

    Enca Martin-Rendon

  23. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review

    Article • European Heart Journal, June 2008, European Society of Cardiology

    Enca Martin-Rendon

  24. Stem cell treatment for acute myocardial infarction

    Article • April 2007, Wiley

    Enca Martin-Rendon

  25. The murine ortholog of the SHP‐2 binding molecule, PZR accelerates cell migration on fibronectin and is expressed in early embryo formation

    Article • Journal of Cellular Biochemistry, April 2007, Wiley

    Enca Martin-Rendon

  26. Transcriptional Profiling of Human Cord Blood CD133 + and Cultured Bone Marrow Mesenchymal Stem Cells in Response to Hypoxia

    Article • Stem Cells, April 2007, Oxford University Press (OUP)

    Enca Martin-Rendon

  27. Blueprint for the Response of Blood and Bone Marrow-Derived Stem Cells and Their Progeny to Hypoxia

    Article • March 2007, World Scientific Pub Co Pte Lt

    Enca Martin-Rendon

  28. Patenting Human Genes and Stem Cells

    Article • Recent Patents on DNA & Gene Sequences, February 2007, Bentham Science Publishers

    Enca Martin-Rendon

  29. Iron Particles for Noninvasive Monitoring of Bone Marrow Stromal Cell Engraftment into, and Isolation of Viable Engrafted Donor Cells from, the Heart

    Article • Stem Cells, August 2006, Oxford University Press (OUP)

    Enca Martin-Rendon

  30. Glycosylation Defects and Muscular Dystrophy

    Article • January 2005, Springer Science + Business Media

    Enca Martin-Rendon

  31. Exploitation of stem cell plasticity

    Article • Transfusion Medicine, December 2003, Wiley

    Enca Martin-Rendon

  32. Stem cell plasticity

    Article • British Journal of Haematology, September 2003, Wiley

    Enca Martin-Rendon

  33. Protein glycosylation in disease: new insights into the congenital muscular dystrophies

    Article • Trends in Pharmacological Sciences, April 2003, Elsevier

    Enca Martin-Rendon

  34. New Methods to Titrate EIAV-Based Lentiviral Vectors

    Article • Molecular Therapy, May 2002, Elsevier

    Enca Martin-Rendon

  35. [27] Design, production, safety, evaluation, and clinical applications of nonprimate lentiviral vectors

    Article • January 2002, Elsevier

    Enca Martin-Rendon

  36. Production of EIAV based lentiviral vectors for gene therapy

    Article • European Journal of Cancer, April 2001, Elsevier

    Enca Martin-Rendon

  37. Yeast Ty retrotransposons assemble into virus-like particles whose T-numbers depend on the C-terminal length of the capsid protein 1 1Edited by J. Karn

    Article • Journal of Molecular Biology, September 1999, Elsevier

    Enca Martin-Rendon, Professor David Bhella

  38. Cloning and characterization of hIF2, a human homologue of bacterial translation initiation factor 2, and its interaction with HIV-1 matrix

    Article • Biochemical Journal, August 1999, Portland Press Ltd.

    Enca Martin-Rendon

  39. Identification of proteolytic cleavage sites within the gag‐analogue protein of Ty1 virus‐like particles

    Article • Molecular Microbiology, December 1996, Wiley

    Enca Martin-Rendon

  40. Structural determinants within the subunit protein of Ty1 virus‐like particles

    Article • Molecular Microbiology, November 1996, Wiley

    Enca Martin-Rendon

  41. Isolation of a mutant allele that deregulates the threonine biosynthesis in Saccharomyces cerevisiae

    Article • Current Genetics, December 1993, Springer Science + Business Media

    Enca Martin-Rendon